Mini-CABG Preferable Over Stenting For Complex Lesions – NEJM Study
This article was originally published in The Gray Sheet
Executive Summary
Minimally invasive coronary artery bypass grafting (CABG) surgery is associated with fewer major adverse cardiac events and angina symptoms than stenting, a study in the Aug. 22 New England Journal of Medicine concludes
You may also be interested in...
Ventrica Assigns MVP To Team Medtronic; Coalescent Going Solo With U-Clip
Ventrica, Inc. says it expects its MVP coronary (distal) anastomotic connector to sell at a premium to aortic (proximal) clips given the device's potential to encourage greater use of "off-pump" bypass procedures
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.